Alternate Health (CSE:AHG) has announced the acquisition of a new mobile payment processing application acting as a payment solution and point-of-sale technology with comprehensive blockchain reporting.
As quoted in the press release:

“This acquisition is the final piece needed to fully integrate Alternate Health’s cannabis-specific Electronic Medical Records (EMR) and Transaction Management software with Blockchain technology,” says Dr. Michael Murphy, CEO of Alternate Health. “Our complete software suite will ensure full regulatory compliance, empowering governments with detailed financial, tax and transaction reporting and uniquely addressing the demands of the legal cannabis industry.”
The regulated cannabis industry is projected to reach $30 billion USD in the United States by 2021 and up to $22.6 billion CAD in Canada according to respective reports in Forbes and Maclean’s magazines1. With such rapid growth, there are numerous opportunities for technologies that ensure safety, security and transparency. Alternate Health expects to capture of a meaningful percentage of this market by offering governments the tools to track end-to-end transactions in regulated cannabis markets.
“Alternate Health’s software creates a fixed engine to empower local, state and national governments to monitor end-to-end transactions and collect the exact and appropriate remuneration,” says Dr. Murphy. “The new payment solutions and point-of-sale technology bolsters Alternate Health’s intellectual property assets and opens up greater revenue generating capabilities for the Company’s patented EMR and transaction management software.”


Click here to read the full press release.

American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.

Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.

Keep reading... Show less

An Emerging Markets Sponsored Commentary

Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.

Keep reading... Show less

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less